Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) is focused on the research, development and commercialization of novel treatments for serious and unmet medical needs by identifying and investigating potential drugs and plant-based therapies, such as cannabinoids, that may be repurposed for new indications, be delivered in a different way, combined with existing drugs, or be developed as new chemical entities or prodrugs.  Revive’s drug discovery approach combines bioinformatics and drug development relationships with leading researchers and institutions.